Flamel Technologies S.A.

(FLML) Trade

By |

Profile

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.

Contact Information

Website: www.avadel.com
Main Phone: +353 14851200
Address: Block 10-1, Blanchardstown
Address 2: Corporate Park, Ballycoolin
City / Town: Dublin
Country: IRL
Postal Code: 15

Issuer Information

Exchange: NSD
CEO: Michael S. Anderson
Employees: 180
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 15.45 52 Wk Low 7.56
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,241,254.00 EPS (TTM) 0.61 PE Ratio 17.00 Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 35 35 35 35
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 23.25 23.25 23.25 23.25
Standard Deviation 9.54 9.54 9.54 9.54
Date of Most Recent Estimate 11/08/16 11/08/16 11/08/16 11/08/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1